News
-
New Podcast Episode: Valentina’s Lymphoma Story and personalised CAR T-cell Therapy
For Valentina, changing homes and continents was meant to mark a new beginning. However, the diagnosis of lymphoma came just as everything seemed ready. Within hours, her life was turned upside down, culminating in an experimental treatment at the time: CAR T-cell therapy.
-
TRANSCAN JTC2026 – Translational Research on Cancer Metabolism
The TRANSCAN project has pre-announced its JTC2026, focusing on ‘Translational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatment’. The call will launch on 20 May 2026. Pre-proposals must be submitted by 21 July 2026.
-
WHO Report on AI in Health Care across EU Member States
WHO/Europe has published a new report assessing the use of artificial intelligence (AI) in health care across the 27 European Union Member States. The report shows that AI is becoming increasingly embedded in health systems, with all EU countries recognising its potential to improve patient care.
-
PRECISEU Call: Advancing Interregional Innovation in Personalised Medicine
The PRECISEU project has published a call to support innovative interregional projects in personalised medicine under the Regional Innovation Valleys framework. The call will empower SMEs, startups and innovation actors to develop and scale solutions in ATMPs and health data, strengthening regional ecosystems and accelerating the uptake of high-impact, patient-centred innovations across Europe.
Showcasing Impactful Research and Collaborations in Personalised Medicine
The EP PerMed success stories highlight the remarkable achievements and outcomes of projects funded under EP PerMed & ERA PerMed. These stories demonstrate the tangible impact of research in personalised medicine, from groundbreaking scientific discoveries to advancements in clinical practice, innovative methodologies, and collaborations that drive progress in healthcare.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.